Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

New AIDS drug leaps over the counter.

[No authors listed]

Science. 1993 Jul 23;261(5120):422-3. No abstract available.

PMID:
8332905
2.

Taking the HIV factory tour.

Armistead HS; International AIDS Society..

Ann Trop Paediatr. 2001 Sep;21(3):191-4. Review. No abstract available.

PMID:
11579856
3.

Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries.

Bourinbaiar AS, Jirathitikal V.

Curr Pharm Des. 2003;9(18):1419-31. Review.

PMID:
12769722
4.

Advances in HIV/AIDS therapy.

Johnson SC, Gerber JG.

Adv Intern Med. 2000;45:1-40. Review.

PMID:
10635044
5.

[HIV-AIDS 2004: New substances, new targets for treatment, future therapeutic strategies].

Delessert K, Schiffer V, Hirschel B.

Rev Med Suisse. 2005 Jan 5;1(1):73-8. Review. French.

PMID:
15773202
6.

Alternative strategies for anti-HIV treatment.

Eron JJ Jr, Vernazza P.

AIDS. 2001;15 Suppl 5:S161-9. Review.

PMID:
11816165
7.

Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention.

Kelly JA, Otto-Salaj LL, Sikkema KJ, Pinkerton SD, Bloom FR.

Health Psychol. 1998 Jul;17(4):310-9. Review.

PMID:
9697940
8.

HIV chemotherapy.

Richman DD.

Nature. 2001 Apr 19;410(6831):995-1001. Review.

PMID:
11309630
9.

HIV/AIDS and return to work: a literature review one-decade post-introduction of combination therapy (HAART).

Braveman B, Levin M, Kielhofner G, Finlayson M.

Work. 2006;27(3):295-303. Review.

PMID:
17006006
10.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
11.

Treatment of HIV disease in the new millennium.

Kak V, MacArthur RD, Crane LR.

Semin Thorac Cardiovasc Surg. 2000 Apr;12(2):140-4. Review.

PMID:
10807436
12.

New drugs for old.

Winston A, Stebbing J.

J HIV Ther. 2005 Mar;10(1):11-6. Review.

PMID:
15951729
13.

Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.

Vyas TK, Shah L, Amiji MM.

Expert Opin Drug Deliv. 2006 Sep;3(5):613-28. Review.

PMID:
16948557
14.

HIV and AIDS in inpatient dermatology. Approach to the consultation.

Finkelstein M, Berman B.

Dermatol Clin. 2000 Jul;18(3):509-20, x. Review.

PMID:
10943545
15.

HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.

Wilson LE, Gallant JE.

Clin Infect Dis. 2009 Jan 15;48(2):214-21. doi: 10.1086/595701. Review.

PMID:
19072245
16.

[Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects].

Villani P, Cocchi L, Giacchino R, Seminari E, Regazzi MB, Maserati R.

Clin Ter. 1996 Jun;147(6):279-93. Review. Italian.

PMID:
8925637
17.

Research developments in HIV/AIDS.

Mitruka K, Boyle B.

AIDS Read. 2002 Jan;12(1):12-6. Review. No abstract available.

PMID:
11862654

Supplemental Content

Support Center